Table 2 Abnormal clinical signs and mortality in rats orally treated with PM012
From: Safety and efficacy assessment of standardized herbal formula PM012
Sex | Dose (mg/kg) | Observations | |
|---|---|---|---|
| Â | Â | 0-4 Weeks | 0-26 Weeks |
Male | 0 | Appears normal | Appears normal |
| Â | 500 | Appears normal | Appears normal |
| Â | 1000 | Appears normal | Appears normal |
| Â | 2000 | Appears normal | Appears normal |
Female | 0 | Appears normal | Appears normal |
| Â | 500 | Appears normal | Appears normal |
| Â | 1000 | Appears normal | Appears normal |
| Â | 2000 | Appears normal | Appears normal |